3Owens DR. Repaglinide--prandial glucose regulator,a new class of oral antidiabetic drugs [J]. Diabeted,1998,15(supp1 4) :28.
4Timmermans PB. pharmacokinetics of antiotensin I(AT1) recept or antagonists [J]. Car J cardiol, 1999,15(suppl F) :26.
5Israili ZH. Clinical pharmacokinetics of angiotensin I receptor blockers in hypertension [ J ]. J. Hum Hypertens, 2000,14 (suppl 1 ) : 73.
6Oparil S. Newly emerging pharmacologic differences in angiotensin I receptor blockers [J]. Am J Hypertens, 2000,13 (2):18.
7Shokei kim,Yumei zhan,Yasukatsu zsumi. Cardiovascular Effects of combination of perindopril,candesartan, and Amlodipine in Hypertensive Rats [J].Hypertension, 2000,2000 (4) : 769.
8Hernandez Hernandez R, Velasco M, Armas Hernandez MJ,et al. Angiotensin I receptor antagonists in arterial hypertension [J]. J Hum Hypertens,2000,14(suppl 1 ) :69.
9Qin-Gui Xia, Oliver chung, Thomas unger.significance of Timing of Angiotensin AT1 Receptor Blockade in Rats with Myocardial infarction-induced Heart Failure[J]. Cardiovascular Research, 2001,49(1):10.
10Jain M ,Liao R,Ngoy s ,Anglotensin I receptor blockadl attenuates the deleterions effects of exercise training on post-MI ventricular remodelling in Rats [J].Cardiovasc Res, 2000,46(1):66.
